ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620129 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620129; 2) Community: the network communities that were significantly associated with the response to NSC 620129; 3) Molecule: the relationships between components within communities and NSC 620129; 4) MDR: the compounds that were significantly associated with the NSC 620129.

NSC Compound Enrichment Correlation
NSC 750100 4-[5-(phenyl)-3-(methylselenocyanide) pyrazol-1-yl]benzenesulfonamide 0.0329129886465387 -0.3153487
NSC 753598 Null 0.0329129886465387 0.33563858
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0329129886465387 0.10868696
NSC 81280 Null 0.0329129886465387 0.14367543
NSC 106246 Null 0.0329129886465389 0.11907486
NSC 169434 component of Monistat cream 0.0329129886465389 0.15831239
NSC 357114 CS-12350 0.0329129886465389 -0.051738474
NSC 405159 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, 4-oxo-.alpha.-phenyl-, oxime 0.0329129886465389 0.29136865
NSC 56410 Porfiromycin 0.0329129886465389 -0.025515335
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.0329129886465389 -0.066784433
Total:74  Current:55    [First] [Prev] [Next] [Last]